Significance of antibodies to streptokinase in coronary thrombolytic therapy with streptokinase or APSAC
- 31 October 1988
- journal article
- Published by Elsevier in Fibrinolysis
- Vol. 2 (4) , 203-210
- https://doi.org/10.1016/0268-9499(88)90014-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarctionThe American Journal of Cardiology, 1988
- Systemic effects of thrombolytic drugs in acute myocardial infarction: Comparison of intravenous APSAC (BRL 26921) and intracoronary streptokinaseFibrinolysis, 1987
- IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Thrombolytic therapy in patients with acute myocardial infarction.Circulation, 1985
- Relationship of the lytic state to successful reperfusion with standard- and low-dose intracoronary streptokinase.Circulation, 1985
- Fibrinolytic effects of intracoronary streptokinase administration in patients with acute myocardial infarction and coronary insufficiency.Circulation, 1983
- Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapyNature, 1981
- THE MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN. I. INDUCTION AND EFFECTS*Journal of Clinical Investigation, 1959
- The Clearance of Heterologous Protein from the Circulation of Normal and Immunized Man12Journal of Clinical Investigation, 1958